Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Adv Neurobiol ; 18: 53-83, 2017.
Article in English | MEDLINE | ID: mdl-28889263

ABSTRACT

The antagonism of mercury toxicity by selenium has been well documented. Mercury is a toxic metal, widespread in the environment. The main target organs (kidneys, lungs, or brain) of mercury vary depending on its chemical forms (inorganic or organic). Selenium is a semimetal essential to mammalian life as part of the amino acid selenocysteine, which is required to the synthesis of the selenoproteins. This chapter has the aim of disclosing the role of selenide or hydrogen selenide (Se-2 or HSe-) as central metabolite of selenium and as an important antidote of the electrophilic mercury forms (particularly, Hg2+ and MeHg). Emphasis will be centered on the neurotoxicity of electrophile forms of mercury and selenium. The controversial participation of electrophile mercury and selenium forms in the development of some neurodegenerative disease will be briefly presented. The potential pharmacological use of organoseleno compounds (Ebselen and diphenyl diselenide) in the treatment of mercury poisoning will be considered. The central role of thiol (-SH) and selenol (-SeH) groups as the generic targets of electrophile mercury forms and the need of new in silico tools to guide the future biological researches will be commented.


Subject(s)
Brain/metabolism , Mercury Poisoning, Nervous System/metabolism , Neurotoxicity Syndromes/etiology , Selenium/poisoning , Antidotes/therapeutic use , Azoles/therapeutic use , Benzene Derivatives/therapeutic use , Humans , Isoindoles , Mercury Poisoning/drug therapy , Mercury Poisoning/metabolism , Mercury Poisoning, Nervous System/drug therapy , Neurotoxicity Syndromes/drug therapy , Neurotoxicity Syndromes/metabolism , Organoselenium Compounds/therapeutic use , Selenoproteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL